Good morning :)
Switch to
Place Order

Divi's Laboratories Ltd

DIVISLAB
Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹99,613 cr, stock is ranked 43
Low RiskStock is 1.57x as volatile as Nifty
3,752.3537.20 (+1.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹99,613 cr, stock is ranked 43
Low RiskStock is 1.57x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
72.36
PB RatioPB Ratio
13.62
Dividend YieldDiv. Yield
0.42%
Sector PESector PE
63.73
Sector PBSector PB
8.02
Sector Div YldSctr Div Yld
292.81%

Forecast & RatingsDetailed Forecast 

78%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

Brands

Divi's

Pharmaceutical company

Brands

Divi's

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20172018201920204.134.005.105.581.060.871.351.37
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnApr 6, 2021

Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 | Download

Trading Window 
Announced OnMar 31, 2021

Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Cash Dividend 
Ex. DateFeb 25, 2020

Interim • Div/Share: ₹ 16

See all events